This program will focus on heightened risk factors for publicly traded companies when providing information to investors and provide insights about such risk factors using the recent securities fraud class action filed against Inovio Pharmaceuticals ...
The panelists will examine key funding, oversight, and enforcement provisions in the CARES Act, along with practical guidance. The panelists will discuss examples of how businesses could end up in trouble, the type of things and how it could happen, ...
The presentation will first examine three recent SEC pronouncements advising publicly traded companies to be making focused disclosures about how the pandemic is affecting their current operations and is likely to impact future operations, then discu...
This presentation will begin with a retrospective assessment of the CARES Act legislation and related regulatory measures promulgated by key federal agencies to implement this landmark law and provide needed assistance to businesses and individuals a...
Matthew Chester, Esq.
Thomas H. Barnard, Esq.
Laura E. Collins, Esq.
James Holloway, Esq.
Mark Schnapp, Esq.
Robert Hauberg, Jr., Esq.